We are live on ! Find out more
Impax Asset Management Group

Impax Asset Management Group Portfolio holdings

AUM $14.3B
1-Year Est. Return 19.8%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+19.8%
3 Year Est. Return
+49.05%
5 Year Est. Return
+63.44%
10 Year Est. Return
AUM
$16B
AUM Growth
-$1.15B
Cap. Flow
-$789M
Cap. Flow %
-4.94%
Top 10 Hldgs %
30.02%
Holding
294
New
19
Increased
65
Reduced
119
Closed
15

Top Sells

Rank Stock Value
1
ORA icon
Ormat Technologies
ORA
+$119M
2
ORCL icon
Oracle
ORCL
+$103M
3
SNPS icon
Synopsys
SNPS
+$79.6M
4
VLTO icon
Veralto
VLTO
+$70.2M
5
RNR icon
RenaissanceRe
RNR
+$65.9M

Sector Composition

Rank Sector Weight
1 Industrials 36.63%
2 Technology 26.57%
3 Healthcare 10.71%
4 Financials 7.61%
5 Materials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALV icon
151
Autoliv
ALV
$9.02B
$9.78M 0.06%
82,394
+6,634
+9% +$792K
ELV icon
152
Elevance Health
ELV
$81.5B
$9.76M 0.06%
27,843
-451
-2% -$152K
GEV icon
153
GE Vernova
GEV
$264B
$9.24M 0.06%
+14,137
New +$8.61M
PG icon
154
Procter & Gamble
PG
$336B
$9.22M 0.06%
64,338
-1,616
-2% -$238K
RVTY icon
155
Revvity
RVTY
$12.6B
$9.17M 0.06%
+94,762
New +$9.1M
WH icon
156
Wyndham Hotels & Resorts
WH
$5.56B
$9.07M 0.06%
120,000
RIVN icon
157
Rivian
RIVN
$22B
$8.87M 0.06%
450,000
CMI icon
158
Cummins
CMI
$87.5B
$8.85M 0.06%
17,338
-2,945
-15% -$1.38M
MMSI icon
159
Merit Medical Systems
MMSI
$5.07B
$8.81M 0.06%
100,000
TVTX icon
160
Travere Therapeutics
TVTX
$5.2B
$8.6M 0.05%
225,000
-250,000
-53% -$8.13M
FRPT icon
161
Freshpet
FRPT
$2.93B
$8.53M 0.05%
140,000
+70,000
+100% +$3.97M
WRBY icon
162
Warby Parker
WRBY
$3.28B
$8.39M 0.05%
385,000
OTIS icon
163
Otis Worldwide
OTIS
$27.4B
$8.37M 0.05%
95,841
-16,737
-15% -$1.5M
CAH icon
164
Cardinal Health
CAH
$53.9B
$8.36M 0.05%
40,681
+201
+0.5% +$37.8K
HPE icon
165
Hewlett Packard
HPE
$63.4B
$8.2M 0.05%
341,417
-7,865
-2% -$185K
KO icon
166
Coca-Cola
KO
$377B
$8.17M 0.05%
116,891
-3,393
-3% -$237K
TRS icon
167
TriMas Corp
TRS
$1.43B
$8.15M 0.05%
230,000
ACN icon
168
Accenture
ACN
$102B
$8.06M 0.05%
30,025
-704
-2% -$179K
PBH icon
169
Prestige Consumer Healthcare
PBH
$2.38B
$8.02M 0.05%
130,000
+20,000
+18% +$1.22M
MAR icon
170
Marriott International
MAR
$98.3B
$7.88M 0.05%
25,390
-737
-3% -$211K
CWST icon
171
Casella Waste Systems
CWST
$5.71B
$7.84M 0.05%
80,000
DIS icon
172
Walt Disney
DIS
$167B
$7.82M 0.05%
68,734
-146,771
-68% -$16.2M
BMY icon
173
Bristol-Myers Squibb
BMY
$133B
$7.8M 0.05%
144,677
-3,367
-2% -$162K
WGS icon
174
GeneDx Holdings
WGS
$1.93B
$7.8M 0.05%
60,000
+10,000
+20% +$1.37M
VITL icon
175
Vital Farms
VITL
$545M
$7.63M 0.05%
238,915
+130,000
+119% +$4.58M

Similar funds

Impax Asset Management Group's Q4 2025 Portfolio in Review

As of Q4 2025, Impax Asset Management Group held 294 positions worth $16B, down 6.7% from $17.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Impax Asset Management Group withdrew a net $789M in Q4 2025, closing 15 positions and reducing 119 holdings. Its most notable exit was Carlisle Companies, an estimated $25.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 37% of assets, down from 37% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Impax Asset Management Group opened a new position in Tyler Technologies worth $107M.

  • Impax Asset Management Group's largest Q4 2025 buy was Tyler Technologies: 235,136 shares worth $107M.
  • Impax Asset Management Group added most to American Water Works in Q4 2025, an estimated $87.9M increase.
  • Impax Asset Management Group's biggest Q4 2025 reduction was Ormat Technologies, cutting an estimated $119M.
  • Impax Asset Management Group fully exited Carlisle Companies in Q4 2025, selling an estimated $25.5M.
  • Impax Asset Management Group's ten largest holdings make up 30% of its $16B portfolio in Q4 2025.
  • Impax Asset Management Group opened 19 new positions and closed 15 in Q4 2025.
  • Impax Asset Management Group's portfolio value fell 6.7% quarter-over-quarter to $16B.

Based on Impax Asset Management Group's 13F filing for Q4 2025, filed 29 Jan 2026.